Sfoglia per Autore
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer : Between Biomarkers and Novel Cell-Based Approaches
2021 M. Ghidini, A. Petrillo, A. Botticelli, D. Trapani, A. Parisi, A. La Salvia, E. Sajjadi, R. Piciotti, N. Fusco, S. Khakoo
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology
2021 C. Criscitiello, E. Guerini-Rocco, G. Viale, C. Fumagalli, E. Sajjadi, K. Venetis, R. Piciotti, M. Invernizzi, U. Malapelle, N. Fusco
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
2021 K. Venetis, R. Piciotti, E. Sajjadi, M. Invernizzi, S. Morganti, C. Criscitiello, N. Fusco
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
2021 C. Blundo, M. Giroda, N. Fusco, E. Sajjadi, K. Venetis, M.C. Leonardi, E. Vicini, L. Despini, C.F. Rossi, L. Runza, M.S. Sfondrini, R. Piciotti, E. Di Loreto, G. Scarfone, E. Guerini-Rocco, G. Viale, P. Veronesi, B. Buonomo, F.A. Peccatori, V.E. Galimberti
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
2022 E. Sajjadi, G. Gaudioso, A. Terrasi, F. Boggio, K. Venetis, M. Ivanova, L. Bertolasi, G. Lopez, L. Runza, A. Premoli, D. Lorenzini, E. Guerini-Rocco, S. Ferrero, V. Vaira, N. Fusco
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
2022 K. Venetis, E. Crimini, E. Sajjadi, C. Corti, E. Guerini-Rocco, G. Viale, G. Curigliano, C. Criscitiello, N. Fusco
A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast
2022 L. Nicosia, A.C. Bozzini, S. Penco, C. Trentin, M. Pizzamiglio, M. Lazzeroni, G. Lissidini, P. Veronesi, G. Farante, S. Frassoni, V. Bagnardi, C. Fodor, N. Fusco, E. Sajjadi, E. Cassano, F. Pesapane
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
2022 A. de Sire, L. Lippi, K. Venetis, S. Morganti, E. Sajjadi, C. Curci, A. Ammendolia, C. Criscitiello, N. Fusco, M. Invernizzi
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
2022 N. Fusco, E. Sajjadi, K. Venetis, M. Ivanova, S. Andaloro, E. Guerini-Rocco, E. Montagna, P. Caldarella, P. Veronesi, M. Colleoni, G. Viale
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
2022 C. Corti, K. Venetis, E. Sajjadi, L. Zattoni, G. Curigliano, N. Fusco
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
2022 E. Sajjadi, K. Venetis, M. Noale, H.A. Azim, C. Blundo, G. Bonizzi, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, M. Barberis, P. Veronesi, V.E. Galimberti, G. Viale, N. Fusco, F.A. Peccatori, E. Guerini-Rocco
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer
2022 S. Morganti, A. Marra, K. Venetis, E. Sajjadi, L. Ascione, C. Corti, P. Zagami, M. Ivanova, L. Zattoni, G. Curigliano, N. Fusco, C. Criscitiello
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022 G. Corso, O. D'Ecclesiis, F. Magnoni, E. Mazzotta, F. Conforti, P. Veronesi, E. Sajjadi, K. Venetis, N. Fusco, S. Gandini
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
Trop-2 as an Actionable Biomarker in Breast Cancer
2023 G. Cursano, E. Frigo, E. Sajjadi, M. Ivanova, K. Venetis, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”
2023 E. Sajjadi, K. Venetis, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile